Clinical Trials Directory

Trials / Completed

CompletedNCT01158053

Vascular Evaluation for Revascularization: Defining the Indications for Coronary Therapy: A Pilot Study

A Prospective, Global, Multicenter, Non-Randomized, Non-Blinded Study in Patients With Intermediate Coronary Lesions to Examine the Correlation Between Fractional Flow Reserve (FFR) and Intravascular Ultrasound With Virtual Histology (VH-IVUS)

Status
Completed
Phase
Study type
Observational
Enrollment
291 (actual)
Sponsor
Volcano Corporation · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The present prospective, multicenter study will therefore be performed with the primary objective of establishing the correlation between fractional flow reserve (FFR) and intravascular ultrasound with virtual histology (VH-IVUS)-derived parameters in angiographically intermediate coronary lesions. The current study will also examine the relative prognostic utility of FFR and VH-IVUS as a tool to defer percutaneous coronary intervention (PCI), by assessing the long-term rate (up to 3 years) of lesion-related clinical events if deferred by FFR vs. VH-IVUS versus not deferred PCI.

Conditions

Interventions

TypeNameDescription
DEVICEFFR and VH-IVUS* Stable Angina(SA), Unstable Angina(UA),Non ST-segment Elevation Myocardial Infarction(NSTEMI) or ST-segment Elevation Myocardial Infarction(STEMI) \>48hrs scheduled for cardiac catheterization ± PCI. All patient level inclusion and no exclusion criteria are met Signed Informed Consent * No PCI or successful and uncomplicated PCI of all non study lesions. One or more study lesions identified. All lesion level inclusion criteria and no exclusion criteria are met. * FFR followed by VH-IVUS of study lesion(s) * Any additional PCI based on routine clinical practice and FFR/IVUS data? * If Yes: Final IVUS with VH imaging, Clinical follow-up at hospital discharge, 30 days, 6 months, and then yearly for 3 years * If No: Clinical follow-up at hospital discharge, 30 days, 6 months, and then yearly for 3 years
DEVICEIVUS and FFR

Timeline

Start date
2010-09-01
Primary completion
2012-04-01
Completion
2015-01-01
First posted
2010-07-08
Last updated
2015-12-10

Source: ClinicalTrials.gov record NCT01158053. Inclusion in this directory is not an endorsement.